1. Clinical outcomes and immune responses to SARS‐CoV‐2 vaccination in severe aplastic anaemia. (21st September 2022) Authors: Rajput, Roma V.; Ma, Xiaoyang; Boswell, Kristin L.; Gaudinski, Martin; Gordon, Ingelise; Novik, Laura; Groarke, Emma M.; Lotter, Jennifer; Superata, Jeanine; Rios, Olga J.; Darden, Ivana; Lin, Bob C.; Jean‐Baptiste, Nazaire; Carroll, Robin; Moore, Christopher; Trost, Jessica; Naisan, Mursal; Will... Journal: British journal of haematology Issue: Volume 199:Number 5(2022) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. (June 2022) Authors: Houser, Katherine V.; Gaudinski, Martin R.; Happe, Myra; Narpala, Sandeep; Verardi, Raffaello; Sarfo, Edward K.; Corrigan, Angela R.; Wu, Richard; Rothwell, Ro Shauna; Novik, Laura; Hendel, Cynthia S.; Gordon, Ingelise J.; Berkowitz, Nina M.; Cartagena, Cora Trelles; Widge, Alicia T.; Coates, Emi... Journal: EClinicalMedicine Issue: Volume 48(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial. Issue 10 (October 2021) Authors: Ruckwardt, Tracy J; Morabito, Kaitlyn M; Phung, Emily; Crank, Michelle C; Costner, Pamela J; Holman, LaSonji A; Chang, Lauren A; Hickman, Somia P; Berkowitz, Nina M; Gordon, Ingelise J; Yamshchikov, Galina V; Gaudinski, Martin R; Lin, Bob; Bailer, Robert; Chen, Man; Ortega-Villa, Ana M; Nguyen, T... Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Issue 10120 (10th February 2018) Authors: Gaudinski, Martin R; Houser, Katherine V; Morabito, Kaitlyn M; Hu, Zonghui; Yamshchikov, Galina; Rothwell, Ro Shauna; Berkowitz, Nina; Mendoza, Floreliz; Saunders, Jamie G; Novik, Laura; Hendel, Cynthia S; Holman, LaSonji A; Gordon, Ingelise J; Cox, Josephine H; Edupuganti, Srilatha; McArthur, Mo... Journal: Lancet Issue: Volume 391:Issue 10120(2018) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Issue 10174 (2nd March 2019) Authors: Gaudinski, Martin R; Coates, Emily E; Novik, Laura; Widge, Alicia; Houser, Katherine V; Burch, Eugeania; Holman, LaSonji A; Gordon, Ingelise J; Chen, Grace L; Carter, Cristina; Nason, Martha; Sitar, Sandra; Yamshchikov, Galina; Berkowitz, Nina; Andrews, Charla; Vazquez, Sandra; Laurencot, Carolyn... Journal: Lancet Issue: Volume 393:Issue 10174(2019) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗